The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study
Joseph A. Jakubowski(Indiana Biosciences Research Institute), David Erlinge(Lund University), Dominick J. Angiolillo(University of Florida), Stefan James(Uppsala University), Patricia Brown(Eli Lilly (United States)), Chunmei Zhou(Eli Lilly (United States)), Kenneth J. Winters(Eli Lilly (United States)), Jurriën M. ten Berg(St. Antonius Ziekenhuis), David S. Small(Eli Lilly (United States)), Brian A. Moser(Eli Lilly (United States))
Cited by 24
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k